Levemir is a long-acting insulin that’s used to control high blood sugar levels in adults and children with type 1 and type 2 diabetes. There are alternative insulins that could replace Levemir ...

Trials including commercially available formulations of insulin detemir or insulin glargine were compared with NPH. Pertinent English-language clinical trials published between 2000 and 2006 were ...

The first insulins varied greatly in purity and strength. Manufacturers improved purification techniques, introduced standardized strengths and developed new long-acting insulins. Although not ...

Not all insulin types are the same. Pharmaceutical manufacturers make long-acting, intermediate-acting, and short-acting insulin options. If you do inject insulin, the best way to start a ...

Use of the long-acting insulin analogs glargine and detemir does not reduce the risk of diabetic ketoacidosis in children and adolescents with type 1 diabetes mellitus (T1DM), compared with the ...

In the meantime, Novo Nordisk has responded to the threat from the cut-price fast and long-acting insulins with newer insulins that aim to improve on the performance of the established rivals.

and Elizabeth Warren, D-Mass., said the company's decision to discontinue Levemir, a long-acting insulin, "failed to take into consideration patient access to affordable, long-acting insulin ...